Atlas Trials

The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Study

Clinical trial NCT06958627 · RECRUITING

Trial details

NCT number
NCT06958627
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
HER2 Positive Breast CancerPyrotinib Treatment
Start date
2024-04-30
Primary completion
2025-04-30
Enrollment
964

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.